Executive Leadership Team

Duncan McKay

Senior Vice President, General Manager of Europe

Duncan McKay currently serves as Sangamo’s Senior Vice President and General Manager of Europe. He has over 30 years of experience in the pharmaceutical industry across R&D and commercial strategy, business development, risk management, compliance and communications. Throughout his career Mr. McKay obtained regulatory approval for over 10 new medicines for patients in major markets. Prior to joining Sangamo in 2018, he held various leadership positions at GlaxoSmithKline (GSK), from 2000 to 2015, in Emerging Markets R&D, Oncology R&D and Clinical Operations of Europe. While at GSK, Mr. McKay developed a high value portfolio of patented and non-patented medicines and created access for several million new patients, played an integral role in the design and creation of Oncology R&D within the organization and successfully led pivotal registration clinical studies for three new oncology medicines. Earlier in his career, he worked in clinical development at Beecham Research Laboratories and SmithKline Beecham, legacy companies of GSK.

Mr. McKay received a B.S. in Biochemistry from the University of Surrey and his M.B.A. from Henley Business School in the United Kingdom.